Caredx Ev To Operating Cash Flow vs Price To Sales Ratio Analysis

CDNA Stock

USD 25.12 1.01 4.19%

Caredx financial indicator trend analysis is way more than just evaluating Caredx Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Caredx Inc is a good investment. Please check the relationship between Caredx Ev To Operating Cash Flow and its Price To Sales Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ev To Operating Cash Flow vs Price To Sales Ratio

Ev To Operating Cash Flow vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Caredx Inc Ev To Operating Cash Flow account and Price To Sales Ratio. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Caredx's Ev To Operating Cash Flow and Price To Sales Ratio is -0.07. Overlapping area represents the amount of variation of Ev To Operating Cash Flow that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Caredx Inc, assuming nothing else is changed. The correlation between historical values of Caredx's Ev To Operating Cash Flow and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Operating Cash Flow of Caredx Inc are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Ev To Operating Cash Flow i.e., Caredx's Ev To Operating Cash Flow and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.07

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ev To Operating Cash Flow

A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Caredx Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Caredx sales, a figure that is much harder to manipulate than other Caredx Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Caredx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Caredx Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At present, Caredx's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 148.1 K, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.

	2021	2022	2023	2024 (projected)
Interest Expense	9.6M	3.8M	4.3M	3.7M
Depreciation And Amortization	11.9M	16.0M	19.8M	20.8M

Interest Expense Depreciation And Amortization

Caredx fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.45	0.92	0.9	0.96	-0.21	0.93	0.64	-0.69	-0.86	0.97	0.75	0.95	0.13	-0.32	0.47	0.94	0.99	0.89	0.88	0.73	-0.17	0.97	0.91	0.95	0.29
Short Long Term Debt Total	0.45		0.48	0.58	0.35	0.04	0.57	0.01	0.06	-0.43	0.37	0.06	0.49	0.13	-0.1	0.13	0.41	0.43	0.3	0.29	0.34	0.12	0.54	0.32	0.4	0.38
Other Current Liab	0.92	0.48		0.98	0.91	-0.03	0.78	0.66	-0.69	-0.75	0.9	0.75	0.86	-0.08	-0.12	0.59	0.94	0.89	0.86	0.93	0.62	-0.29	0.87	0.92	0.87	0.16
Total Current Liabilities	0.9	0.58	0.98		0.89	0.08	0.78	0.59	-0.61	-0.76	0.88	0.68	0.88	-0.04	-0.13	0.48	0.89	0.86	0.86	0.91	0.61	-0.32	0.88	0.87	0.88	0.14
Total Stockholder Equity	0.96	0.35	0.91	0.89		-0.09	0.82	0.66	-0.74	-0.76	0.92	0.79	0.89	-0.06	-0.15	0.43	0.93	0.93	0.9	0.9	0.67	-0.45	0.89	0.91	0.95	-0.01
Other Liab	-0.21	0.04	-0.03	0.08	-0.09		-0.33	-0.13	0.12	0.09	-0.11	-0.12	-0.06	-0.24	0.43	0.1	-0.25	-0.25	0.11	0.08	-0.16	-0.42	-0.12	-0.15	-0.04	-0.41
Property Plant And Equipment Net	0.93	0.57	0.78	0.78	0.82	-0.33		0.37	-0.41	-0.92	0.9	0.49	0.94	0.34	-0.54	0.39	0.8	0.94	0.81	0.75	0.84	0.07	0.96	0.72	0.89	0.49
Current Deferred Revenue	0.64	0.01	0.66	0.59	0.66	-0.13	0.37		-0.97	-0.29	0.62	0.97	0.45	-0.18	0.16	0.32	0.75	0.6	0.46	0.55	0.0	-0.24	0.5	0.86	0.5	0.03
Net Debt	-0.69	0.06	-0.69	-0.61	-0.74	0.12	-0.41	-0.97		0.35	-0.67	-0.99	-0.5	0.18	-0.12	-0.37	-0.79	-0.64	-0.56	-0.64	-0.11	0.36	-0.54	-0.89	-0.58	0.08
Retained Earnings	-0.86	-0.43	-0.75	-0.76	-0.76	0.09	-0.92	-0.29	0.35		-0.92	-0.42	-0.96	-0.5	0.65	-0.47	-0.68	-0.86	-0.91	-0.8	-0.84	-0.03	-0.94	-0.63	-0.92	-0.45
Accounts Payable	0.97	0.37	0.9	0.88	0.92	-0.11	0.9	0.62	-0.67	-0.92		0.73	0.97	0.26	-0.43	0.48	0.87	0.95	0.94	0.89	0.72	-0.15	0.97	0.86	0.97	0.31
Cash	0.75	0.06	0.75	0.68	0.79	-0.12	0.49	0.97	-0.99	-0.42	0.73		0.58	-0.15	0.09	0.38	0.84	0.7	0.6	0.68	0.16	-0.34	0.62	0.93	0.64	-0.02
Non Current Assets Total	0.95	0.49	0.86	0.88	0.89	-0.06	0.94	0.45	-0.5	-0.96	0.97	0.58		0.29	-0.46	0.43	0.8	0.94	0.95	0.87	0.81	-0.15	0.99	0.77	0.98	0.31
Non Currrent Assets Other	0.13	0.13	-0.08	-0.04	-0.06	-0.24	0.34	-0.18	0.18	-0.5	0.26	-0.15	0.29		-0.89	-0.08	-0.1	0.11	0.17	-0.07	0.2	0.54	0.27	-0.12	0.21	0.61
Other Assets	-0.32	-0.1	-0.12	-0.13	-0.15	0.43	-0.54	0.16	-0.12	0.65	-0.43	0.09	-0.46	-0.89		0.03	-0.1	-0.33	-0.36	-0.16	-0.51	-0.45	-0.44	-0.03	-0.39	-0.59
Long Term Debt	0.47	0.13	0.59	0.48	0.43	0.1	0.39	0.32	-0.37	-0.47	0.48	0.38	0.43	-0.08	0.03		0.52	0.49	0.52	0.67	0.46	0.0	0.43	0.51	0.45	0.19
Cash And Short Term Investments	0.94	0.41	0.94	0.89	0.93	-0.25	0.8	0.75	-0.79	-0.68	0.87	0.84	0.8	-0.1	-0.1	0.52		0.92	0.77	0.87	0.57	-0.25	0.84	0.97	0.84	0.16
Net Receivables	0.99	0.43	0.89	0.86	0.93	-0.25	0.94	0.6	-0.64	-0.86	0.95	0.7	0.94	0.11	-0.33	0.49	0.92		0.87	0.88	0.77	-0.12	0.96	0.89	0.93	0.32
Common Stock Total Equity	0.89	0.3	0.86	0.86	0.9	0.11	0.81	0.46	-0.56	-0.91	0.94	0.6	0.95	0.17	-0.36	0.52	0.77	0.87		0.93	0.79	-0.34	0.91	0.75	0.97	0.11
Common Stock Shares Outstanding	0.88	0.29	0.93	0.91	0.9	0.08	0.75	0.55	-0.64	-0.8	0.89	0.68	0.87	-0.07	-0.16	0.67	0.87	0.88	0.93		0.74	-0.37	0.85	0.85	0.9	0.05
Short Term Investments	0.73	0.34	0.62	0.61	0.67	-0.16	0.84	0.0	-0.11	-0.84	0.72	0.16	0.81	0.2	-0.51	0.46	0.57	0.77	0.79	0.74		-0.04	0.78	0.44	0.79	0.29
Non Current Liabilities Total	-0.17	0.12	-0.29	-0.32	-0.45	-0.42	0.07	-0.24	0.36	-0.03	-0.15	-0.34	-0.15	0.54	-0.45	0.0	-0.25	-0.12	-0.34	-0.37	-0.04		-0.08	-0.29	-0.31	0.88
Inventory	0.97	0.54	0.87	0.88	0.89	-0.12	0.96	0.5	-0.54	-0.94	0.97	0.62	0.99	0.27	-0.44	0.43	0.84	0.96	0.91	0.85	0.78	-0.08		0.81	0.96	0.38
Other Current Assets	0.91	0.32	0.92	0.87	0.91	-0.15	0.72	0.86	-0.89	-0.63	0.86	0.93	0.77	-0.12	-0.03	0.51	0.97	0.89	0.75	0.85	0.44	-0.29	0.81		0.81	0.11
Other Stockholder Equity	0.95	0.4	0.87	0.88	0.95	-0.04	0.89	0.5	-0.58	-0.92	0.97	0.64	0.98	0.21	-0.39	0.45	0.84	0.93	0.97	0.9	0.79	-0.31	0.96	0.81		0.15
Total Liab	0.29	0.38	0.16	0.14	-0.01	-0.41	0.49	0.03	0.08	-0.45	0.31	-0.02	0.31	0.61	-0.59	0.19	0.16	0.32	0.11	0.05	0.29	0.88	0.38	0.11	0.15

Click cells to compare fundamentals

Caredx Account Relationship Matchups

Caredx fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	151.7M	368.5M	566.6M	543.0M	466.8M	490.2M
Short Long Term Debt Total	3.0M	16.1M	17.4M	39.0M	34.2M	20.7M
Other Current Liab	22.6M	57.5M	60.0M	55.1M	54.5M	29.1M
Total Current Liabilities	34.8M	69.2M	77.3M	76.0M	78.1M	43.4M
Total Stockholder Equity	99M	277.7M	465.9M	430.9M	261.3M	274.4M
Other Liab	14.8M	5.5M	6.1M	2.7M	3.1M	2.9M
Property Plant And Equipment Net	9.2M	25.9M	40.0M	70.2M	65.1M	68.4M
Current Deferred Revenue	3.7M	20.5M	55.3M	5.3M	4.7M	8.4M
Net Debt	(35.2M)	(118.6M)	(331.1M)	(50.9M)	(48.0M)	(50.4M)
Retained Earnings	(333.8M)	(352.5M)	(383.2M)	(460.4M)	(678.3M)	(644.4M)
Accounts Payable	5.5M	9.7M	13.3M	9.9M	12.9M	13.5M
Cash	38.2M	134.7M	348.5M	89.9M	82.2M	79.7M
Non Current Assets Total	79.8M	95.4M	133.3M	155.1M	170.9M	179.4M
Non Currrent Assets Other	(5.5M)	(9.6M)	(5.7M)	(14.0M)	19.1M	20.1M
Other Assets	1.3M	1.3M	6.0M	4.4M	(17.8M)	(16.9M)
Cash And Short Term Investments	38.2M	224.7M	348.5M	293.1M	235.4M	120.6M
Net Receivables	24.1M	34.6M	59.8M	66.3M	51.1M	53.6M
Common Stock Total Equity	41K	42K	49K	52K	59.8K	62.8K
Common Stock Shares Outstanding	42.2M	46.5M	52.2M	53.3M	53.8M	32.9M
Liabilities And Stockholders Equity	151.7M	368.5M	566.6M	543.0M	466.8M	490.2M
Non Current Liabilities Total	17.9M	21.6M	23.4M	36.1M	127.4M	133.8M
Inventory	6.0M	10.0M	17.2M	19.2M	19.5M	20.4M
Other Current Assets	3.6M	7.5M	15.9M	9.2M	7.8M	4.6M
Other Stockholder Equity	438.0M	632.3M	853.7M	898.8M	946.5M	993.8M
Total Liab	52.7M	90.8M	100.7M	112.1M	205.5M	215.8M
Property Plant And Equipment Gross	9.2M	25.9M	40.0M	70.2M	97.4M	102.3M
Total Current Assets	71.9M	273.1M	433.4M	387.8M	313.7M	329.4M
Accumulated Other Comprehensive Income	(5.2M)	(2.1M)	(4.7M)	(7.5M)	(7.0M)	(7.3M)
Short Term Debt	3.0M	2.0M	4.0M	5.6M	(2.6M)	(2.5M)
Common Stock	29K	41K	42K	49K	52K	33.1K
Property Plant Equipment	9.2M	25.9M	40.0M	70.2M	80.8M	84.8M
Net Tangible Assets	29.6M	209.5M	378.7M	350.3M	402.9M	423.0M
Retained Earnings Total Equity	(311.8M)	(333.8M)	(352.5M)	(383.2M)	(344.9M)	(362.1M)
Deferred Long Term Liab	4.1M	2.0M	1.3M	415K	373.5K	354.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Caredx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caredx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:

How To Invest In Caredx

Details

Is Caredx Stock a good investment?

Details

What is Caredx's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Stocks Directory module to find actively traded stocks across global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caredx. If investors know Caredx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caredx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.69)

Revenue Per Share

5.952

Quarterly Revenue Growth

0.234

Return On Assets

(0.07)

Return On Equity

(0.43)

The market value of Caredx Inc is measured differently than its book value, which is the value of Caredx that is recorded on the company's balance sheet. Investors also form their own opinion of Caredx's value that differs from its market value or its book value, called intrinsic value, which is Caredx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caredx's market value can be influenced by many factors that don't directly affect Caredx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Caredx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caredx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caredx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Caredx Ev To Operating Cash Flow vs Price To Sales Ratio Analysis

Ev To Operating Cash Flow vs Price To Sales Ratio

Ev To Operating Cash Flow vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Ev To Operating Cash Flow

Price To Sales Ratio

Caredx fundamental ratios Correlations

Caredx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Caredx fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Receivables	+ 0.99	Total Assets
Inventory	+ 0.99	Non Current Assets Total
Total Current Liabilities	+ 0.98	Other Current Liab
Other Stockholder Equity	+ 0.98	Non Current Assets Total
Accounts Payable	+ 0.97	Total Assets
Inventory	+ 0.97	Total Assets

Cash	- 0.99	Net Debt
Net Debt	- 0.97	Current Deferred Revenue
Non Current Assets Total	- 0.96	Retained Earnings
Inventory	- 0.94	Retained Earnings
Other Stockholder Equity	- 0.92	Retained Earnings
Accounts Payable	- 0.92	Retained Earnings